BioCentury
ARTICLE | Company News

Neokimia, Trimeris deal

May 6, 2002 7:00 AM UTC

The companies will research and develop small molecule HIV fusion inhibitors. TRMS will screen a library of small molecules from NeoKimia, which will optimize resulting leads. The partners initially w...